Table 1.
The characteristics of the patients
| Characteristics | Value |
|---|---|
| Number of patients | 34 |
| Age (years) | 67 (32–93) |
| Gender, n (%) | |
| Male | 20 |
| Female | 14 |
| Weight (kg) | 56.9 ± 12.0 (35.0–85.0) |
| Height (cm) | 161.4 ± 8.5 (143.0–181.0) |
| BMI (kg/m2) | 21.7 ± 3.4 (15.6–30.1) |
| Fasting blood glucose level (mg/dl) | 105.4 ± 18.8 (73.8–160.2) |
| 18F-FDG injection dose (MBq) | 168.4 ± 35.5 (103.6–251.6) |
| CEA (ng/ml) | 74.5 ± 185.3 (0.92–1033.0) |
| Delay time (min) | 60 ± 4.3 (51–72) |
| Location (number of patients) | |
| Rectal cancer | 1 |
| Colon cancer | 33 |
| Ascending | 11 |
| Transverse | 5 |
| Descending | 10 |
| Sigmoid | 7 |
| TNM | |
| I-II | 6 |
| III | 11 |
| IV | 17 |
| Primary tumour | |
| SUVmax | 21.6 ± 13.9 (7.3–82.7) |
| TBR | 8.8 ± 4.9 (2.9–26.7) |
| Liver metastases | |
| SUVmax | 8.4 ± 5.2 (3.2–22.7) |
| TBR | 3.7 ± 2.2 (1.5–8.4) |
| Size | |
| Largest lesion | 4.6 ± 2.7 (1.0–8.5) |
| Minimal lesion | 0.9 ± 0.4 (0.6–2.1) |